Optimizing Decision-Making in CLL in an Era of Novel Agents
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
PRIME in partnership with the CLL Society and the Leukemia & Lymphoma Society (LLS) offers this endured webcast led by Dr. John Byrd and Dr. Brian Koffman as they address concerns of patients and providers on how to best manage toxicities associated with novel CLL/SLL and FL therapies. Hone your clinical skills with real-world patient cases and listen to effective strategies aimed at improving care coordination, managing and mitigating toxicities, and enhancing transitions of care.
Related posts
